Compare CDLX & MLSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CDLX | MLSS |
|---|---|---|
| Founded | 2008 | 1989 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Programming Data Processing | Industrial Specialties |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 26.0M | 22.1M |
| IPO Year | 2018 | 1996 |
| Metric | CDLX | MLSS |
|---|---|---|
| Price | $3.70 | $0.40 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 2 | 1 |
| Target Price | ★ $2.25 | $1.00 |
| AVG Volume (30 Days) | 55.3K | ★ 129.4K |
| Earning Date | 05-07-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 50.13 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $233,273,000.00 | $8,973,982.00 |
| Revenue This Year | N/A | $12.64 |
| Revenue Next Year | $8.82 | $8.99 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 3.99 |
| 52 Week Low | $0.55 | $0.22 |
| 52 Week High | $6.40 | $0.68 |
| Indicator | CDLX | MLSS |
|---|---|---|
| Relative Strength Index (RSI) | 44.95 | 53.35 |
| Support Level | $0.74 | $0.24 |
| Resistance Level | $4.52 | $0.40 |
| Average True Range (ATR) | 0.30 | 0.03 |
| MACD | -0.14 | 0.00 |
| Stochastic Oscillator | 12.50 | 53.00 |
Cardlytics Inc is a commerce media platform that is designed to make commerce smarter and rewarding for everyone. At the core of its commerce media platform is the financial media network that it runs within its partners' digital channels, which includes online and mobile applications (the Cardlytics platform). Additionally, it operates an identity resolution platform that utilizes point-of-sale (POS) data, including product-level purchase data, to enable marketers to perform analytics and targeted loyalty marketing and also measure the impact of their marketing (the Bridg platform). It operates in three segments: the Cardlytics platform in the U.S.; the Cardlytics platform in the U.K.; and the Bridg platform. The majority of the revenue is derived from the Cardlytics platform.
Milestone Scientific Inc develops and commercializes proprietary computer-controlled drug delivery systems designed to enhance the safety, precision, and patient experience associated with subcutaneous injections and fluid aspiration procedures. The company's core technology platform, Dynamic Pressure Sensing (DPS) Technology, controls flow rate and measures pressure at the needle tip in real time. DPS Technology is incorporated into both the company's dental and medical products and supports clinical applications, including local anesthesia delivery, epidural space identification in regional anesthesia procedures, and intra-articular joint injections. It operates in two segments: Dental, which markets and sells its dental products, and Medical, markets and sells its medical products.